Call Us: 1.800.873.5297


First Trial in DePuy Pinnacle™ MDL Set to Begin In September

The first bellwether trial in the DePuy Pinnacle™ Multidistrict Litigation (In Re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation, Case No. 3:11-md-02244, MDL No. 2244) will begin on September 1, 2014, as set forth in Case Management Order No. 8. The first trial involves cases filed by two plaintiffs: Kathleen Herlihy-Paoli and Toni […]


NuvaRing® Lawsuit Update: $100 Million Settlement Will Be Fully Funded by August 2014

Roger Denton and Kristine Kraft, partners at Schlichter, Bogard & Denton, LLP and Co-Lead Counsel in the NuvaRing® Multidistrict Litigation, report that the $100 million NuvaRing® settlement will be fully funded by mid-August 2014. The terms of the NuvaRing® Master Settlement Agreement have been satisfied, which prompted Federal MDL Judge Rodney Sippel, the St. Louis […]


Roger Denton and Kristine Kraft of Schlichter, Bogard & Denton, LLP Report that the $100 Million NuvaRing Settlement Will Go Forward

Roger Denton and Kristine Kraft of Schlichter, Bogard & Denton, LLP, Co-Lead Counsel in the NuvaRing Multidistrict Litigation, are pleased to announce that the $100 Million global settlement reached in February will go forward as planned. On February 7, 2014, United States District Court Judge Rodney W. Sippel approved a $100 Million settlement in the […]


Actos Lawsuit Update: Verdict in Favor of Takeda in Las Vegas State Court

On May 22, 2014, a Las Vegas state court jury rendered a verdict in favor of Takeda Pharmaceuticals in a case involving two women who ingested the diabetes drug Actos®. Together, Plaintiffs Bertha Triana and Delores Cipriano sought over $56 million in compensatory damages.  The women claimed that Takeda failed to warn them and their […]


Actos® MDL Trial Update: Jury Awards Plaintiff $9 Billion in Punitive Damages

The first federal Actos® trial in the MDL concluded on Monday, April 7th. After deliberations, the jury awarded the plaintiff $1.5 million in compensatory damages and $9 billion in punitive damages ($6 billion against Takeda; $3 billion against Eli Lilly). The first trial in the Multidistrict Litigation In re: Actos® (Pioglitazone) Products Liability Litigation (MDL […]


Pradaxa Lawsuit Update (MDL 2385): Recent Articles Raise Issue of Credibility with Company’s own Clinical Trial

The Hamilton Spectator found interest in lawsuits filed in July 2013 by Samuel Richardson of Castlewood, Va. and Billie Jean Benitez of Fair Oaks, Ca. While these are two plaintiffs amongst nearly 2,300 in the pending Multidistrict Litigation, In re: Pradaxa® (Dabigatran Etexilate) Products Liability Litigation (MDL 2385, Case No. 12-md-2385), who have filed cases […]


New Research: Testosterone Drugs Linked to Increased Risk of Blood Clots, Heart Attack and Stroke

The FDA recently announced the launch of an investigation of the cardiovascular risks associated with testosterone therapy. The medical safety alert is to warn men of potential risks and/or side effects associated with testosterone therapy. Studies have shown that, as early as one month and up to the first 90 days after starting testosterone therapy, dangerous […]


Transvaginal Mesh Lawsuit Update: 200 Additional C.R. Bard Avaulta Cases will be Selected for Trial

The litigation involving C.R. Bard’s Avaulta transvaginal mesh continues to move forward. The Honorable Judge Joseph Goodwin, who presides over the C.R. Bard Multidistrict Litigation (MDL 2187) pending in the Southern District of West Virginia, has issued an order requiring that 200 additional cases be selected for trial. In particular, he is requiring attorneys from […]


Mirena® IUD Lawsuit Update: 36 New Lawsuits Filed in Federal Multidistrict Litigation (MDL 2434)

The number of Mirena® lawsuits continues to grow with 159 lawsuits currently on file in federal court in the Multidistrict Litigation In re: Mirena® IUD Products Liability Litigation (MDL 2434), according to the most recent report issued by the Judicial Panel on Multidistrict Litigation (JPML). The Mirena® MDL is pending in the United States District Court for […]


Kristine Kraft, Partner at Schlichter, Bogard & Denton, LLP, Appears on the Bill Press Show to Discuss Problems with NuvaRing

Kristine K. Kraft, partner at the law firm of Schlichter, Bogard & Denton, LLP, was invited to be a guest on the nationally syndicated Bill Press Show this morning to discuss the NuvaRing® Multidistrict Litigation (MDL) and the problems with NuvaRing®. Kristine has been appointed by The Honorable Judge Rodney W. Sippel of the Eastern […]

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.